For the Quarter Ending September 2025
North America
• In the United States, the Acebutolol Price Index rose quarter-over-quarter in Q3 2025, due to rising input costs.
• Acebutolol production costs increased in Q3 2025, driven by a 2.6% rise in PPI in August 2025.
• Natural gas feedstock costs strengthened significantly in Q3 2025, raising manufacturing expenses.
• The 3.0% CPI increase in September 2025 indicated general inflation, raising operational costs.
• Demand for Acebutolol was supported by continued upward healthcare spending in 2025.
• Retail sales surged 5.42% in September 2025, suggesting consumer economic health.
• A 0.1% industrial production growth in September 2025 indicated sluggish activity.
• The unemployment rate of 4.3% in September 2025 remained moderate, impacting patient access.
• Consumer confidence declined to 94.2 in September 2025, indicating softening economic sentiment.
• US chemical production contracted in Q3 2025, tightening inventories and weakening foreign orders.
Why did the price of Acebutolol change in September 2025 in North America?
• Production costs rose from a 2.6% PPI increase in August 2025 and strengthened natural gas prices.
• Demand was supported by continued upward healthcare spending in 2025, despite weakening chemical markets.
• Tightening finished goods inventories and contracted US chemical production contributed to price pressure.
APAC
• In China, Acebutolol Price Index declined in Q3 2025, influenced by deflationary pressures and lower input costs.
• Acebutolol production costs declined in Q3 2025, driven by a 2.3% fall in PPI and lower benzene prices.
• Demand outlook was mixed; industrial production rose 6.5%, retail sales grew 3.0% in September 2025.
• However, a contracting Manufacturing Index and cautious consumer confidence (89.6) tempered Acebutolol demand.
• The Acebutolol Price Index is forecast to remain under pressure due to persistent deflation and manufacturing sector contraction.
• Energy feedstock costs varied; natural gas production increased, and falling coal prices aided coal-based chemical producers in Q3 2025.
• Sulfuric acid inventories tightened by late Q3 2025, while China's total exports strengthened in September 2025.
• Policy changes included strict controls on new refining projects and phasing out aging units to address overcapacity.
Why did the price of Acebutolol change in September 2025 in APAC?
• Production costs fell due to 2.3% PPI decline and lower benzene spot prices in September 2025.
• Deflationary pressures from 0.3% CPI decline and contracting Manufacturing Index impacted demand in September 2025.
• Strengthening sulfuric acid export prices and tightening inventories provided upward cost pressure in September 2025.
Europe
• In Germany, the Acebutolol Price Index fell quarter-over-quarter in Q3 2025, driven by declining producer prices and reduced propylene feedstock costs.
• Acebutolol production costs faced mixed pressures in Q3 2025, with lower PPI but higher natural gas and electricity prices.
• Demand for Acebutolol remained steady in Q3 2025, supported by the pharmaceutical sector's resilience and an aging population.
• The Manufacturing Index trended Contracting in September 2025, signaling a slowdown in broader industrial activity.
• Germany's industrial production declined by 1.0% year-on-year in September 2025, impacting overall supply chain dynamics.
• Trade flows in Q3 2025 showed weakening German chemical exports and increased imports of goods, including pharmaceuticals.
• The Acebutolol Price Forecast is influenced by continued feedstock cost fluctuations and stable, inelastic pharmaceutical demand.
• Low unemployment at 3.9% in September 2025 supported healthcare funding, despite negative consumer confidence at -23.6.
Why did the price of Acebutolol change in September 2025 in Europe?
• Producer Price Index decreased by 1.7% in September 2025, lowering overall manufacturing input costs.
• Propylene feedstock costs continued to decline in Q3 2025, reducing Acebutolol production expenses.
• Despite rising energy costs, these direct input cost reductions exerted downward price pressure.
For the Quarter Ending December 2022
North America
In the fourth quarter of 2022, the Acebutolol API market in North America experienced a fluctuating trend. Prices began to climb in Q4 2022 and continued to do so throughout the second month of the fourth quarter due to high manufacturing costs, numerous logistical issues, and rising inflation. The US inflation Soar to 8.2% in the month of October 2022.
Additionally contributing to the price fluctuation were rising transportation costs and port congestion at the major ports. However, Prices begin to decline later in the month of December as a result of weaker inflation (the US inflation rate was 7%, down from 8.2% in October) and decreased end-user sector demand as the holiday season approaches. The Acebutolol API settlement price in December fell to USD 95336/MT CFR Los Angeles.
Asia
The Asia Pacific Acebutolol API market saw a turbulent fourth quarter in 2022. It was witnessed that the prices rose considerably till the second month of the quarter due to increased end-user sector demand, several logistical challenges, and rising inflation. The Producer Price Index (PPI) grew by 0.9% while the Consumer Price Index in China increased by 2.8%, both of which had an impact on the market. The "Zero-Covid" policy in China has so far impacted investor confidence and the nation's economic operations. The market remained competitive because of rising production costs brought on by rising energy prices as well as increased domestic output to meet demands from both domestic and foreign markets. Later in December, as domestic merchants had sufficient stock, Acebutolol API prices began to decline. The policies being relaxed and the weak downstream demand influenced the market's ongoing decline. In December, the settlement price for Acebutolol API fell to USD 93590/MT FOB Shanghai.
Europe
In the fourth quarter of 2022, prices for Acebutolol API showcased a soaring trajectory in the European region. The downstream market for the pharmaceutical sector was seen to have a steady demand for Acebutolol API. Price hikes were brought on by ongoing port congestion and supply disruption in the European region throughout Q4 022. Also, the European annual inflation rate was 10.6% in Q4 2022, up from 9.9%. Retailers in Europe make the decision to refill their inventory due to the approaching Christmas season considerably. Also, to ease the inflationary pressure, the market players were propelled to raise their quotations in order to slow down the demand and consumer consumption. The cost of Acebutolol API was USD 100270/MT CFR Hamburg toward the end of Q4 2022.
For the Quarter Ending September 2022
North America
The price trends of Acebutolol have witnessed declining market dynamics in the third quarter of 2022. The hampered trade activities across the globe have severely influenced the price chain of Acebutolol in the regional market. The rising inflation has further supported Acebutolol's depleting market values among traders due to lowering demand from the end-user industry. At the termination of Q3 2022, the cost accessed at USD 101020/MT with an average quarterly declination of 2.14%. In addition, lower production and input costs drove Acebutolol costs lower across the regional market throughout the third quarter.
APAC
During the third quarter of 2022, the Acebutolol market witnessed plunging behavior in the Asia- Pacific region. The Acebutolol prices depreciate throughout the quarter due to lackluster demand from the terminal pharmaceutical sector. Also, the slowed economy, sufficient supplies, and enough inventories supported this downward price trend. Weak demand fundamentals and regular supply led the Acebutolol market to continue its downward trend. Towards the end of the second half of Q3, prices significantly escalated amid the increased inquiries from the domestic and international markets. Also, hampered supply owing to former production halts and trade activities following extreme weather in Condon and zero covid policies affected the market in the last month. At the termination of Q2 2022, the values accessed at USD 91080/MT with an average quarterly declination of 1.45%.
Europe
The Acebutolol market has truncated in the third quarter of 2022 amid poor demand dynamics from the downstream pharmaceutical sector. At the termination of Q3 2022, the values accessed at USD 104800/MT with an average quarterly declination of 3.21%. The plunging values have also been triggered by decreasing offtakes from the regional market, which led to a muted trading dynamic. The end-user supplier and traders were bargaining over their existing stockpiled goods to maintain their profit margins. Operating costs and raw material prices continued to decline, and purchasing activities fell somewhat. All these variables influenced the dwindling market dynamics with a negative price movement for Acebutolol.
For the Quarter Ending June 2022
North America
The price trends of Acebutolol have witnessed inclining market sentiments in the second quarter of 2022. The COVID-19 resurgence and hampered trade activities across the globe have severely hampered the price value chain of Acebutolol in the regional market. The raging inflation and soaring energy costs have further supported Acebutolol's escalated market values among the traders. Furthermore, constrained imported cargo flow pressurized the margin among the downstream pharmaceutical ventures affecting the sales and revenues. At the termination of Q2 2022, the values accessed at USD 108000/MT with the average quarterly inclination of 2.90%. The finished drug market also remained affected by surging demand from end consumers. In addition, Logistical issues and a scarcity of containers drove higher Acebutolol costs across the regional market throughout the second quarter.
APAC
During the second quarter of 2022, the price trends of Acebutolol oscillated in the Asia- Pacific region. The prices improved throughout the quarter due to active demand from the terminal sector. The acebutolol market continues its uptrend in the Indian domestic market owing to speculations around the global supply chains and strong demand fundamentals. The prices have significantly escalated since the beginning of second quarter amid the increased inquiries from domestic and international market players. Furthermore, the hampered trade activities in China have also provoked the limited availability of the products for the importing countries. As supply-side concerns escalated in the region, the manufacturers corrected their quotations in the second quarter. At the termination of Q2 2022, the values accessed at USD 95220/MT with the average quarterly inclination of 1.94%.
Europe
The Acebutolol market has expanded in the second quarter amid robust demand from downstream pharmaceutical companies. The active covid cases and global supply turmoil unleashed by Russia’s invasion of Ukraine have severely impacted the market sentiments of Acebutolol in the regional market. The volatility in energy costs has also exerted enough cost pressure on the market value of Acebutolol in the regional market. The domestic manufacturers have increased their production capacities to meet the demand from the downstream pharmaceutical firms. At the termination of Q2 2022, the values accessed at USD 115860/MT with the average quarterly inclination of 1.66%. Furthermore, the limited availability of Chinese supplies amid the stringent lockdown measures has pressurized the price dynamics of Acebutolol throughout the second quarter.
